Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-14-069945

Options or other derivatives

  • VP - Preclinical Research acquired 28,140 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dondero Richard S · VP - Preclinical Research

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2014-11-18 Grant or award : show line 1 in the form Common Stock Option (right to buy) +28,140 49,476 D
Loading xslF345X03/form471634_20141120093230-.xml…